A. Choudhury

Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-β1 signaling mechanism

This study identifies MMP11 as a blood-based biomarker for prostate cancer progression, regulated by the ALDH1A1-TGF-β1 signaling pathway.

Epigenetic reprogramming shapes the cellular landscape of schwannoma

This study identifies two molecular groups in schwannomas driven by epigenetic reprogramming and shows ionizing radiation can reprogram neural crest to immune-enriched schwannomas.

Glioma-neuronal circuit remodeling induces regional immunosuppression

This study shows that glioma-induced neuronal circuit remodeling creates regional immunosuppression in glioblastomas by altering tumor-associated macrophages and T-cell infiltration.

NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy

This study identifies NOTCH3 as a driver of meningioma tumorigenesis and radiotherapy resistance, showing its role in tumor growth and survival in preclinical models.

Co-enrichment of cancer-associated bacterial taxa is correlated with immune cell infiltrates in esophageal tumor tissue

The paper identifies four bacterial taxa enriched in esophageal cancer and links their co-occurrence to immune cell infiltration patterns in tumor tissues.

Assessment of local potato cultivars found in Cis-Himalayan region of West Bengal through morphology and biochemical profiling

This study evaluates local potato cultivars from North Bengal for morphology and anthocyanin content to identify stable genotypes with high tuber yield and antioxidant properties.

Glioblastoma remodeling of neural circuits in the human brain decreases survival

This study shows glioblastomas alter neural circuits in the human brain, reducing survival and impairing cognition through synaptogenic interactions.

Isolation of Genomic Deoxyxylulose Phosphate Reductoisomerase (DXR) Mutations Conferring Resistance to Fosmidomycin

The paper identifies mutations in the IspC gene of E. coli that confer resistance to fosmidomycin, a malaria drug, using CRISPR-based screening.